Synthesis of 7,12-dihydropyrido[3,4-b:5,4-b']diindoles. A novel class of rigid, planar benzodiazepine receptor ligands.
Synthesis of 7,12-dihydropyrido[3,4-b:5,4-b']diindoles. A novel class of rigid, planar benzodiazepine receptor ligands.
复制标题
7,12-二氢吡啶并[3,4-b:5,4-b]二吲哚的合成。
DOI:
10.1021/jm00386a003
复制
发表时间:
1987
影响因子:
7.3
通讯作者:
Cook,JM
中科院分区:
文献类型:
--
作者:
Trudell,ML;Basile,AS;Shannon,HE;Skolnick,P;Cook,JM
The practice of incorporating biofunctionality into a rigid framework to enhance activity or selectivity of action is by no means new. The early work of Bentley et al. 1 2in the morphine area serves as an excellent example. While structure-activity relationship studies23-1 suggest that one necessary criteria for high-affinity binding of ligands to benzodiazepine receptors (Bz R) is the ability of these molecules to assume a planar or pseudoplanar topogra-phy, 23-1 to our knowledge no completely rigid compounds with a planar geometry havebeen shown to bind with high affinity to Bz R. We now report the synthesis of high-affinity ligands of the Bz R that originated from studies directed toward this goal. These molecules are based on the 7, 12-dihydropyrido [3, 2-6: 5, 4-6 d diindole system 2 and have been shown to possess high affinity (5-15 nM, see Table I) for Bz R. Moreover, substitution on the E ring of the pyridodiindoles has a marked effect on both the in vitro binding affinity and the pharmacological activity of these compounds: replacement of eitherhydrogen or methoxyl at position 2 of 2 by a chlorine atom results in a change in the activity from an inverse agonist to an antagonist.High-affinity, stereoselective binding sites for benzodiazepines in the mammalian central nervous system are currently thought to mediate the principal pharmacological actions of the benzodiazepines. 3 Since the discovery of these receptors in 1977, at least one-half dozen unique classes of compounds have been shown to bind to these sites. Such compounds have been shown to produce a wide range of pharmacologic actions that vary from those that are virtually indistinguishable from benzodiazepines (eg, zopiclone) 4 to “inverse agonists” that produce convulsions, 5 reduce sleep, 6 and produce a syndrome resembling fear or anxiety in primates. 7 Other compounds, such as the pyrazoloquinolinones8 CGS-9896, CGS-9895, and CGS-8216